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Purpose: To investigate the capacity of cultured Müller cells to synthesize collagens, since previous studies indicated
that Müller cells could be involved in collagen remodeling at the vitreoretinal border in adult human eyes.
Methods: Spontaneously immortalized cultured human Müller cells were analyzed for the presence of mRNA of types
I-VII, IX, XI, and XVII collagen by RT–PCR. Furthermore, Müller cells were immunocytochemically stained for light
microscopic (LM) evaluation of these collagens and their main characteristics. Finally, cell extracts and culture medium
were evaluated by western blot (WB) analysis using anticollagen antibodies.
Results: Cultured Müller cells contained mRNA for types I-VII, IX, and XI collagen, but not for type XVII collagen. LM
and WB confirmed the intracellular expression of all the above-mentioned collagens with the exception of type XVII.
Collagen secretion into the medium was established for types I-VII, IX, and XI collagen.
Conclusions: Cultured Müller cells can synthesize internal limiting lamina and vitreous collagens. Possible collagen
production by Müller cells could explain and expand on previous in vivo morphological findings in the embryonic and
postnatal period and in pathologic conditions.
Müller cells are radially oriented macroglia that traverse
the retina from its inner (vitreal) border to the outer limiting
membrane.  These  cells  have  many  local  functions:  they
stabilize  the  retinal  architecture,  provide  an  orientation
scaffold,  give  structural  and  metabolic  support  to  retinal
neurons and blood vessels, and prevent aberrant photoreceptor
migration into the subretinal space [1,2]. In vivo and in vitro,
Müller  cells  can  produce  and  express  several  cytokines,
growth factors, and receptors [2]. Other features of Müller
cells  are  the  expression  of  cellular  retinaldehyde  binding
protein  (CRALBP),  vimentin,  and,  on  activation,  glial
fibrillary acidic protein (GFAP) [3,4]. A possible role in the
production of vitreous macromolecules during growth and in
adulthood has been suggested [5,6], but little is known about
their  capability  to  produce  vitreous  and  internal  limiting
lamina (ILL) collagens postnatally. Whether Müller cells are
capable of producing basement membrane components is a
matter of debate. Some studies find evidence hereof [7-12],
while others fail to confirm it [13-15].
Recently, turnover and remodeling of vitreous collagen
was described in human donor eyes. Evidence for collagen
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breakdown in matrix areas bordering liquefied spaces was
found in the human vitreous [16]. In addition to collagen
breakdown, a study on vitreous collagens and two studies on
the  vitreoretinal  interface  found  evidence  of  postnatal
collagen synthesis in the human eye. The first detected type
II procollagens in the vitreous [17] and the latter two described
intraretinal fibers and isolated packages of vitreous collagen
(type  II)  [18,19].  On  aging,  intraretinal  collagen  fibers
expanded under the ILL at the vitreous base into networks and
made contact with the basal vitreous, leading to the formation
of  vitreoretinal  collagen  connections  [18].  We  observed
comparable intraretinal packages of vitreous collagen, often
associated  with  surrounding  Müller  cell  processes,  focal
interruptions of the ILL, and the presence of macrophages and
cell debris. These findings could be consistent with a process
of interactive remodeling with a net synthesis of vitreous
collagens.  Because  of  their  close  proximity  to  collagen
packages, Müller cells may be involved in this process of
matrix remodeling [19].
The present study evaluates the in vitro capacity of the
human Müller cell line, MIO-M1 [4], to synthesize (1) known
vitreous collagens (i.e., types II, V/XI, VI, and IX) [20], (2)
ILL collagens (types IV and VI; unpublished data of our
group) [19,21], (3) type VII collagen [22] (which appears to
be  present  in  the  human  retina  by  immunohistochemical
staining;  unpublished  data  of  our  group),  (4)  collagens
described in epiretinal and vitreoretinal membranes (types I-
V) [23,24], and (5) a collagen not related to the vitreoretinal
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652interface (the hemidesmosomal transmembrane type XVII
collagen  found  in  basement  membranes  of  stratified  and
pseudostratified epithelia) [25]. In this in vitro model, we
demonstrate  the  capacity  of  Müller  cells  for  collagen
production, cytoplasmic expression of collagens, and their
secretion into the cell medium.
METHODS
Culture  of  cells:  The  spontaneously  immortalized  human
Müller  cell  line  MIO-M1  (a  kind  gift  of  G.A.  Limb,
Moorfields/Institute of Ophthalmology, London, UK) has all
the characteristics of human retinal Müller cells [4]. The cells
were cultured to confluence in Dulbecco’s modification of
Eagle’s  medium  (DMEM)  high  glucose  containing  L-
glutamax I (Life Technologies Inc., Rockville, MD), 10%
fetal bovine serum (FBS; Life Technologies Inc.) and 1%
penicillin/streptomycin.
For  western  blot  (WB)  analyses  of  the  supernatant,
Müller cells were cultured in DMEM high glucose containing
L-glutamax I without FBS and supplemented with 1% G5
(Life  Technologies  Inc.),  0.2  mM  β-aminopropionitrile
fumurate  salt  (β-APN;  Sigma,  St.  Louis,  MO),  0.2  mM
ascorbic acid (Sigma), and 1% penicillin/streptomycin, since
10%  FBS  caused  clotting  of  the  medium  after  our
concentration  procedure.  The  serum-free  medium  with
supplements  was  introduced  after  24  h  to  allow  uniform
attachment of the Müller cells. Ascorbic acid promotes the
intracellular hydroxylation of prolyl and lysyl residues during
collagen synthesis [26], whereas β-APN inhibits the enzyme
lysyl  oxidase  in  the  extracellular  space  thus  preventing
collagen cross-link formation [27].
Reverse transcriptase-polymerase chain reaction: Total RNA
from  the  Müller  cells  was  extracted  by  RNeasy  Mini  kit
method (Qiagen, Venlo, the Netherlands) according to the
manufacturer’s  instructions.  To  eliminate  DNA
contamination,  we  treated  RNA  samples  with  DNase
treatment Ambion-kit (DNA-free). RNA concentration and
purity were determined on a spectrophotometer (Nanodrop,
Isogen, Maarssen, the Netherlands) by calculating the ratio of
optical density at wavelengths of 260 and 280 nm. Two μg
RNA was reverse transcribed into cDNA using M-MuLV
reverse  transcriptase  (MBI  Fermentas,  St.  Leon-Rot,
Germany) according to manufacturer’s protocol for a total
reaction of 20 μl.
For the PCR reaction, 1 μl cDNA was added to 23 μl
“master mix” consisting of 2.5 μl 10×PCR buffer, 2.5 μl 2 mM
dNTP mix, 1.5 μl 25 mM MgCl2, 0.25 μl (5 U/μl) Taq DNA
polymerase (Fermentas) and 16.25 μl milli-Q water. Finally,
a total of 1 μl of the two specific flanking primers (50 μM)
was added (Table 1). The mixtures were initially denatured at
94 °C for 5 min. The PCR consisted of 35 cycles at the
following  conditions:  denaturation  at  94  °C  for  0.5  min,
annealing at 55 °C (for types I, II, III, V, and IX collagen) and
at 58 °C (for types IV, VI, VII, XI, and XVII collagen) for 1
min, and an extension period at 72 °C for 1 min. These cycles
were followed by a final extension period at 72 °C of 10 min.
PCR products were analyzed by agarose gel electrophoresis
(1%) with 500 ng/ml ethidium bromide. Keratinocytes were
used as positive control for type XVII collagen.
Immunocytochemistry:  By  light  microscopy  (LM),  Müller
cells  were  identified  by  their  morphology  and  by  their
expression of CRALBP, vimentin, and GFAP. The expression
of  cellular  characteristics  was  measured  in  at  least  three
microscopic  areas  at  a  magnification  of  10  times.  To
determine  the  intracellular  expression  of  collagens,  we
specifically  stained  Müller  cells  with  antibodies  against
human types I-VII, IX, XI, and XVII collagen.
For immunocytochemical staining, cells were seeded for
48 h in glass chamber slides. After fixation with 1:1 acetone/
methanol for 10 min at −20 °C, the slides were washed with
phosphate buffered saline (PBS) and pre-incubated for 30 min
with 3% serum of the producer of the secondary antibody in
PBS  with  2%  BSA  (BSA)  (Sanquin,  Amsterdam,  the
Netherlands), followed by incubation for 1 h with primary
TABLE 1. OVERVIEW OF ALL PRIMERS USED IN THE RT–PCR ANALYSIS
Collagen mRNA Forward primer 5′→3′ Reverse primer 5′→3′
Size
(bp)
COL1A1 TCG GCG AGA GCA TGA CCG ATG GAT GAC GCT GTA GGT GAA GCG GCT GTT 254
COL2A1 GTG GAA GAG TGG AGA CTA CTG TGT ACG TGA ACC TGC TAT TG 419
COL3A1 ACC GAT GAG ATT ATG ACT TCA CT CTG CAC ATC AAG GAC ATC TTC AG 369
COL4A2 ATC GGC TAC CTC CTG GTG AA GCT GAT GTG TGT GCG GAT GA 648
COL5A1 GAC TAC GCG GAC GGC ATG GAA CCT GCC AGG CCA CTG ACT GGT A 454
COL6A1 GGA GCT CAA GGA AGC CAT CAA G TCC TCC AGC AGC TCT GCA TAG T 342
COL7A1 CCG AGG ACG AGA TGG TGA AGT TG CTG GCT CCA GGT CCT GTG TCT AC 261
COL9A1 GCC TCT GGT GAA GAA GGT GAA TGC TGA TCT GTC GGT GCT CTA 245
COL11A1 CAG CAG GCT CGG ATT GCT CTG A GGC CAT CTA CAC CTG CCA TAC C 460
COL17A1 ATG GAG CTG CTC ATC ATG AC AGG AGT AGC AGC CAG GTG AG 364
COL1A1 indicates mRNA of the α1 chain of type I collagen.
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653antibodies diluted 1:50 in PBS with 1% BSA. In the case of
types VI, VII, IX, and XI collagen, the latter step was preceded
by  blocking  steps  with  avidin  and  biotin.  The  primary
antibodies  included  the  following:  rabbit  polyclonal
antibodies against CRALBP (UW55, a kind gift from J.C.
Saari, University of Washington, Seattle, WA) and human
types I, III, V (Abcam, Cambridge, UK), and XI collagen (a
kind  gift  from  J.  Oxford,  Boise  State  University,  Boise,
Idaho);  a  biotinylated  rabbit  polyclonal  antibody  against
human type VI collagen (Abcam); goat polyclonal antihuman
antibodies  against  types  II  and  IV  collagen  (Southern
Biotechnology  Associates,  Birmingham,  AL);  and  mouse
monoclonal antihuman antibodies against vimentin (DAKO,
Glostrup, Denmark), GFAP (Sigma), and types VII (Abcam),
IX  (USBiological,  Swampscott,  MA)  and  XVII  collagen
(1A8C [28]; a kind gift from K. Owaribe, Nagoya University,
Japan).  Subsequently,  cells  were  washed  with  PBS  and
endogenous peroxidases were blocked. Secondary antibodies
included  a  swine-antirabbit  peroxidase  (DAKO),  a
biotinylated  goat-antirabbit  (GARbio,  DAKO),  a  rabbit-
antigoat peroxidase (DAKO), a rabbit-antimouse peroxidase
(DAKO),  a  biotinylated  goat-antimouse  IgG1  (GAMbio,
SBA), and a biotinylated goat-antimouse IgG2a (GAMbio,
SBA). Secondary antibodies were diluted 1:100 with PBS
containing 2% human serum was derived from a pool of
human volunteers and added for 1 h at room temperature.
Biotinylated type VI collagen, GARbio, and GAMbio (IgG1
and IgG2) were followed by incubation with ABC complex
horse radish peroxidase (DAKO) for 20 min. Finally, cells
were stained with 3-amino-9-ethylcarbazole (AEC; Sigma)
and  hematoxylin.  Negative  controls  underwent  the  entire
procedure, except for the substitution of the primary antibody.
Isolation  of  cell  extract  and  supernatant
concentration—Cells  were  harvested  in  sodium  dodecyl
sulfate  PAGE  (SDS–PAGE)  denaturation  buffer  (10  mM
Tris-HCl, pH 7 containing 1 mM EDTA, 2.5% SDS, 5% 2-
mercaptoethanol, and 10% glycerol). The extract was heated
for 5 min at 100 °C to unfold the collagen helices into separate
α-chains.
After dead cells and cellular debris were removed by
centrifuging at 1,600 rpm for 5 min, the supernatant was
concentrated by ultrafiltration with an Amicon membrane
(100,000 kDa cut-off; Millipore, Billerica, MA) and, in the
case of collagen XI, with a Vivaspin 0.5 ml concentrator
(30,000 kDa cut-off; Vivascience, Hanover, Germany).
Figure  1.  RT–PCR  on  Müller  cell
extracts.  From  left  to  right,  bands
indicating the positions of types I, II, III,
IV,  V,  VI,  VII,  IX,  XI,  and  XVII
collagen are depicted. At the left margin,
a 100 bp DNA ladder has been added.
Figure  2.  Immunocytochemical
analyses  of  cultured  Müller  cells  in
medium  with  fetal  bovine  serum.  A:
Type  I  collagen  shows  a  granular
staining  with  a  variable  intensity
between cells. B: Type II collagen is
seen as a faint staining in the cytoplasm.
C: Type III collagen is positive in all
cells. D: Type IV collagen is visible as
a strong granular cytoplasmic staining.
E:  Type  V  collagen  shows  mainly
staining in the cytoplasm. F: In the case
of  type  VI  collagen,  the  cells  are
predominantly stained in the cytoplasm.
G: Type VII collagen is faintly positive
in the cytoplasm. H: Type IX collagen
is also present in the cytoplasm. I: Type
XI  collagen  is  primarily  seen  in  the
cytoplasm. Bars in all panels equal 50
μm.
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654Immunoblotting  procedure—Polyacrylamide  SDS
electrophoresis was performed according to the method of
Laemmli [29], using 3.9% and 5% slab gels and a 72-mm wide
2D gel comb in the Bio-Rad Mini Protean II electrophoresis
apparatus (Bio-Rad, Hercules, CA). After separation, the gel
was blotted to nitrocellulose using the Mini Protean II blotting
unit (Bio-Rad) with 22 mM Tris, 168 mM Glycine, 0.05%
SDS, and 20% methanol as a transfer buffer. After the transfer,
the nitrocellulose was blocked for 1 h in TBS-buffer (20 mM
Tris-HCl and 500 mM NaCl; pH 7.5) containing 3% BSA.
Primary antibodies (Table 2) were diluted 1:500 in TBS and
added to the blot. After incubation overnight, the blot was
washed with TBS containing 0.05% Tween-20 (TTBS), and
then secondary antibodies (Table 2) diluted 1:500 in TTBS
were added. After 1 h incubation, the blot was washed with
TTBS  and  incubated  with  alkaline  phosphatase  (AP)-
conjugated tertiary antibody (Table 2) diluted 1:250 in TTBS
for another hour. After washing with TTBS and AP buffer
(100 mM Tris-HCl, 100 mM NaCl, and 5 mM MgCl2, pH 9.5),
the blot was developed with nitro blue tetrazolium and 5-
bromo-4-chloro-3-indolyl  phosphate  in  AP  buffer.  All
incubation  and  washing  steps  were  performed  at  room
temperature.
Collagenase digestion—Cell extracts were mixed with
CaCl2 to a final concentration of 10 mM to inactivate EDTA.
Type VII collagenase (high purity grade, Sigma) was added
in  increasing  concentrations  (0–30  units/ml)  to  60 μl  cell
extract and incubated for 1 h at 37 °C. Previously, the absence
of nonspecific proteases in this collagenase batch had been
confirmed  [30].  To  confirm  that  type  VII  collagenase
specifically cleaves collagen, we exposed Müller cell extracts
to  this  collagenase,  after  which  vimentin  and  CRALBP
expressions were checked. After incubation, samples were
mixed  with  SDS–PAGE  sample  buffer  to  inactivate
collagenase activity.
Cell viability—To determine cell viability, Müller cells
and their medium supplemented with 1% G5, 0.2 mM β-APN,
and 0.2 mM ascorbic acid were harvested and compared to a
well with 10% FBS, which served as a reference, after an
incubation period of 48 h. Dead cells were stained with trypan
blue,  counted  in  a  Bürker-Türker  counter  (W.  Schreck,
Hofheim, Germany), and compared to viable cells.
RESULTS
Reverse  transcriptase  polymerase  chain  reaction:  Müller
cells expressed mRNA of all tested collagen types, except for
type XVII collagen (Figure 1). Amplimers were seen at the
expected positions, which are for COL1A1 at 254 bps, for
COL2A1 at 419 bps, for COL3A1 at 369 bps, for COL4A2 at
648 bps, for COL5A1 at 454 bps, for COL6A1 at 342 bps, for
COL7A1  at  261  bps,  for  COL9A1  at  245  bps,  and  for
COL11A1 at 460 bps. COL17A1 gave no product band as
expected.  Keratinocytes  contained  COL17A1  (figure  not
shown).
Immunocytochemistry: LM results revealed that Müller cells
preserved  their  morphology  and  characteristics  under  the
culture method with FBS. They were all positive for vimentin
and CRALBP, and less than 5% of the cells were GFAP
positive (pictures not shown). In the case of collagen staining,
the cytoplasm of all Müller cells was positive for all collagens
with the exception of type XVII collagen (Table 3; Figures
2A-I).  The  pattern  of  the  cytoplasmic  staining  varied  in
intensity and had a granular to fibrillary aspect. Types V, VI,
and XI collagen also stained positively outside the cell—e.g.,
as small granules and fibers. All negative controls showed no
staining (not shown).
TABLE 2. OVERVIEW OF THE WESTERN BLOT RESULTS
Collagen Molecular weight of collagen
bands in Müller cells
Moleculr weight of collagen
bands in culture medium
Molecular weight of collagen bands
after type VII collagenase
Type I 140 kDa 140 kDa None
Type II 150 kDa 150 kDa None
Type III 180 kDa 180 kDa None
Type IV 130 and 210 kDa 130 and 210 kDa 75, 90, 110, and 250 kDa
Type V 260 kDa 260 kDa None
Type VI 120 and 230 kDa 120 and 230 kDa 150 kDa
Type VII 270 kDa 270 kDa 130, 135, and 140 kDa
Type IX 200 kDa 150 and 200 kDa None
Type XI 100, 150, and 200 kDa 150 kDa None
Type XVII None None None
By SDS–PAGE, collagen secretion into the medium was established for types I-VII, IX, and XI collagen. The specific collagen
antibodies detected the collagen bands (in kDa) obtained before and after treatment with type VII collagenase. The results of
both Müller cell extracts and medium with G5 are shown. The results after type VII collagenase concern Müller cell extracts
and confirm the collagen nature of the bands as seen by WB. “None” indicates no collagen bands were detected.
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655Western  blot:  Cell  extracts  of  Müller  cells  were
immunoblotted for the presence of types I-VII, IX, XI, and
XVII collagen and showed specific collagen bands (Table 2;
Figures  3A-C),  which  disappeared  on  treatment  with
increasing doses of type VII collagenase, except for type XVII
collagen which showed no band. In the case of types IV, VI,
and  VII  collagens  (Figure  3C),  new  product  bands  were
detected after collagenase treatment. The collagenase had no
effect on the bands of CRALBP and vimentin (not shown).
Analysis of conditioned growth medium with G5: Without
FBS  but  with  G5,  Müller  cells  preserved  their
immunocytochemical  characteristics,  although,
morphologically,  they  appeared  a  little  stretched.  Cell
viability  remained  above  95%  with  a  slightly  diminished
proliferation rate compared to conditions with 10% FBS. In
comparison with cells grown in the medium with FBS, the
RT–PCR results were similar. LM results were comparable
but showed less intense intracellular and more extracellular
staining for types I, II, V, and XI collagen. Types I and V
collagen were visible outside the cell as fibrillar threads and
types II and XI collagen also, but to a lesser extent and they
had a more granular aspect (Figures 4A-D). In the medium,
we found specific collagen bands (Table 2) similar to those
detected in the cell extracts except for type IX collagen where
in addition to the 200 kDa band a weak band at 150 kDa was
present. For type XI collagen, only the 150 kDa band was
detected in the medium.
Figure  3.  Examples  of  western  blot
analyses: Müller cell extracts with the
addition of type VII collagenase (0, 10,
and 30 units/ml). A: The specific band
of type II collagen is shown at 150 kDa
and  disappears  without  formation  of
new bands when type VII collagenase is
added. B: At 180 kDa, the specific band
of type III collagen disappears gradually
on the addition of type VII collagenase.
C: Addition of type VII collagenase to
type VII collagen results in the gradual
disappearance  of  the  specific  band  at
270  kDa  and  the  appearance  of
breakdown products at 130, 135, and
140 kDa. Specific bands are indicated
with arrows.
Figure  4.  Immunocytochemical
analyses  of  cultured  Müller  cells  in
medium with G5. Types I (A) and V
(C)  collagen  show  clear  extracellular
fibrillar  threads  and  less  intracellular
staining compared to Figures 2A and
2E, respectively. Types II (B) and XI
(D)  collagen  show  some  fine
extracellular threads and small granules
(arrows)  and  decreased  intracellular
staining compared to Figures 2B and 2I,
respectively. In the inlays of Figures 4B
and  4D,  the  extracellular  collagen  is
magnified two times. Bars in each panel
equal 50 μm.
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656DISCUSSION
This study shows collagen synthesis by human retinal Müller
cells in vitro. Müller cells expressed mRNAs coding for types
I-VII,  IX,  and  XI  collagen.  At  the  protein  level,  these
collagens  were  demonstrated  by  immunocytochemical
staining and shown to be present in the cytoplasm with LM.
WB analysis of the cell extracts and of the medium in which
the  cells  had  been  cultured  confirmed  the  intracellular
production and demonstrated that types I-VII, IX, and XI
collagen were also secreted into the medium. The detected
collagen bands could be procollagen chains as well as collagen
chains,  but  we  did  not  analyze  this.  Müller  cells  did  not
express type XVII collagen, a basement membrane protein
that was recently demonstrated near photoreceptor synapses
and  its  outer  segments  [25].  Apparently,  Müller  cells
synthesize  those  collagens  that  are  found  in  their  natural
vicinity (vitreous, ILL, and retina).
Although the spontaneously immortalized Müller cells
have been well characterized [4] and shown to keep their main
characteristics,  cell  models  in  general  have  as  a  major
limitation that they are artificial in vitro systems unlike an in
vivo model. Cultured Müller cells therefore might display
somewhat deviant behavior because the cells are not in their
natural surrounding, since they are growing on medium and
moreover  have  shown  spontaneous  immortalization.  To
confirm  our  findings,  primary  isolated  Müller  cells  could
provide additional information, but in vivo data would be
preferable.
For the WB experiments with Müller cells, ascorbic acid
and β-APN were added to stimulate collagen synthesis and
prevent  extracellular  collagen  cross-linking,  respectively
[27,31,32]. The differences in collagen staining observed by
LM—the increased extracellular staining for types I, II, V, and
XI collagen paralleled by a decreased intracellular staining—
were most likely the effect of ascorbic acid. The digestion
experiments with collagenase confirmed the collagen nature
of the bands as seen by WB.
We hypothesize that the in vitro capability of Müller cells
to produce the aforementioned collagens might (1) adduce
support to previously described morphological findings in the
embryonic period [5,6], (2) contribute to the stable level of
postnatal vitreous collagen [33], and (3) explain, in part, the
origin of epiretinal membranes in pathology (see below) [7,
8,34-36].
In  the  embryonic  vitreous,  the  neural  retina  and
sometimes specifically Müller cells are indicated as possible
sources of vitreous and ILL collagens. In chicken embryos,
retina was involved in collagen (e.g., type II) synthesis [37,
38]. In the developing mouse neural retina, mRNA of types II
and IX collagen has been detected [39-41]. In the human
embryo, Müller cells seemed continuous with the vitreous
fibrils (primarily collagen type II) present at the vitreal side
[6,42,43]. The production of vitreous fibrils during embryonic
growth of the eye was ascribed to Müller cells and other cell
types [5,6]. Also, Müller cells were supposed to contribute to
the formation of the ILL in the human embryo [6].
The  postnatal  vitreous  has  long  been  regarded  as  an
almost  inert  extracellular  matrix,  in  which  hardly  any
production or breakdown of its macromolecular components
occurs [20,33,44]. Recent studies question the inertness of the
vitreous body and suggested turnover of vitreous components
[16,18,19,45-52].  Currently,  two  hypotheses  on  vitreous
aging  are  postulated.  The  first  is  a  concept  of  vitreous
destabilization on aging because synchisis (liquefaction) and
syneresis (aggregation of vitreous matrix components) lead to
the formation of spaces and aggregated collagens; the second
TABLE 3. IMMUNOCYTOCHEMICAL ANALYSIS OF HUMAN RETINAL MÜLLER CELLS
Collagen Cytoplasm staining Extracellular staining Cytoplasm aspect
FBS G5 FBS G5 FBS G5
Type I ++ + n.d. ++ Granular Granular
Type II + + n.d. + Diffuse Diffuse - granular
Type III + + n.d. n.d. Diffuse Diffuse
Type IV ++ ++ n.d. n.d. Granular Granular
Type V ++ + Granules ++ Granular - fibrillar Diffuse
Type VI + ++ Granules - fibers n.d. Granular Granular
Type VII + ++ n.d. n.d. Diffuse Granular
Type IX ++ ++ n.d. n.d. Diffuse Diffuse
Type XI ++ + Small granules ++ Diffuse Diffuse
Type XVII - - n.d. n.d. - -
Müller cells were fixed on glass chamber slides and stained with specific antibodies against types I-VII, IX, XI, and XVII
collagen. LM confirmed the intracellular expression of all the above-mentioned collagens except type XVII collagen. The aspect
of the collagen staining differed in aspect (diffuse, granular, or fibrillar) and intensity. In the table, the following symbols and
abbreviations are used: strongly positive (++), positive (+), negative (-), not detected (n.d.), medium with 10% fetal bovine
serum (FBS), and medium with 1% G5 (G5).
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657is  a  view  that  extracellular  breakdown  of  vitreous  matrix
[16] (synchisis) would coincide with production of vitreous
collagen [53-55], leading to an increase in optically dense
structures  over  time.  In  both  views,  the  total  amount  of
collagen in the human vitreous appears to remain stable during
life  [33],  which,  for  the  latter  theory,  may  indicate  that
collagen synthesis and collagen breakdown are in equilibrium.
The in vitro capacity of the Müller cell to synthesize vitreous
collagens  suggests  a  possible  role  in  postnatal  vitreous
collagen synthesis. In addition, our in vitro results support the
possible role of Müller cells in the formation of sublaminar
vitreoretinal collagen complexes expanding on aging [11,18,
19].
Müller  cells  are  found  in  epiretinal  membranes  in
pathological circumstances such as massive retinal gliosis,
preretinal macular fibrosis, idiopathic epiretinal membranes,
and  retinal  injuries  or  degeneration  [7,8,34-36].  These
membranes  can  contain  types  I-V  collagen  [23,24].  In
morphological studies, Müller cells appear to contribute to the
formation of pathological membranes [7,8,34]. However, they
may not be the only type of cell involved since glial cells,
astrocytes, fibrocytes, and retinal pigment epithelium have
also been observed in epiretinal membranes [24,56-59].
In summary, the finding that immortalized human Müller
cells synthesize collagens in vitro indicates that they might
also be involved in this process in vivo. Collagen synthesis by
Müller  cells  could  explain  and  expand  on  previous
morphological findings in the embryonic and postnatal period
as well as in pathologic conditions. In vivo experiments will
be necessary to validate our results.
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